Back to News
Market Impact: 0.42
uniQure Stock Crashed on Its Huntington's Data. Wall Street's Price Target Says the Selloff Went Too Far
Source: 247wallst.com
Healthcare & BiotechAnalyst EstimatesInvestor Sentiment & Positioning
uniQure lost more than one-third of its market value in a single trading session after Huntington's disease trial data disappointed investors. Despite the sharp selloff, Wall Street price targets imply triple-digit upside, highlighting a significant disconnect between current market sentiment and analysts' valuation outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.58
Ticker Sentiment
QURE-0.78
More News
- Ten Reasons Investors Are Driving Government Bond Yields Higher
- Tighter New Zealand election race stokes investor fears on policy backflips
- PHC Holdings surge to near 4-year high after Toho takeover proposal confirmed
- Portfolio adviser to the super-rich wanted a bigger stock market correction. Here's why
- Inflation moves in the right direction, but markets are still not out of the woods
- Why is Bajaj Auto stock tumbling today?